Résumé
Un intérêt croissant est porté à l’utilisation des émulsions lipidiques intraveineuses (ELI) en toxicologie clinique depuis une dizaine d’années. Leur administration est à ce jour recommandée uniquement en cas d’arrêt cardiorespiratoire secondaire à une intoxication à la bupivacaïne et en cas d’échec des mesures de réanimation standards pour tout autre toxique cardiotrope et lipophile. Plusieurs mécanismes d’action sont proposés : le piège-siphon lipidique, la modulation du métabolisme myocardique et une action propre hémodynamique; mais le mécanisme d’action réel reste à déterminer. Le schéma d’administration est empirique et de multiples questions restent en suspens. Cette revue refait le point sur le passé, le présent et le futur de l’utilisation thérapeutique des ELI, au vu des dernières publications et recommandations d’experts. Elle apporte des éléments de réflexion quant à l’utilisation pratique des ELI au quotidien. Le niveau de preuve reste très faible. Les ELI ne doivent pas être substituées aux autres moyens de réanimation mais sont une option thérapeutique complémentaire de sauvetage.
Abstract
There has been a growing interest in using intravenous lipid emulsions therapy (ELIs) in acute poisonings for the past decade. Present evidence supports use of ILEs only in local anesthetics-related systemic toxicity especially bupivacaïne and in lipophilic cardiotoxin intoxication when an immediate threat to life exists and other therapies have proven ineffective. Recent works have expanded our understanding of the mechanisms of action including both a dynamic scavenging component and a direct cardiotonic effect; however, its actual mechanism remains to be determined. The dosing regimen is arbitrary and many questions remain unsolved. Here, we discuss the past, present, and future of lipid resuscitation therapy with a focus on our understanding of the mechanisms and latest evidence-based recommendations. This review provides advices about the practical use of ELIs. Consistently, the level of evidence remains very low. ELIs should not be substituted to any other effective resuscitative treatment but be considered as additional rescue therapy.
Références
Hoegberg LC, Bania TC, Lavergne V, Bailey B, Turgeon AF, Thomas SH, Morris M, Miller-Nesbitt A, Mégarbane B, Magder S, Gosselin S, Lipid Emulsion Workgroup, (2016) Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity. Clin Toxicol 54: 167–193
Gosselin S, Hoegberg LC, Hoffman RS, Graudins A, Stork CM, Thomas SH, Stellpflug SJ, Hayes BD, Levine M, Morris M, Nesbitt-Miller A, Turgeon AF, Bailey B, Calello DP, Chuang R, Bania TC, Mégarbane B, Bhalla A, Lavergne V, (2016) Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol 54: 899–923
Mowry JB, Spyker DA, Brooks DE, Zimmerman A, Schauben JL, (2016) 2015 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 33rd Annual Report. Clin Toxicol 54: 924–1109
Russel RL, Westfall BA (1962) Alleviation of barbiturate depression. Anesth Analg 41: 582–585
Shinaberger JH, Shear L, Clayton LE, Barry KG, Knowlton M, (1965) Dialysis for intoxication with lipid soluble drugs: enhancement of glutethimide extrcation with lipid dialysate. Trans Am Soc Artif Intern Organs 11: 173–177
Krieglstein J, Meffert A, Niemeyer DH, (1974) Influence of emulsified fat on chlorpromazine availability in rabbit blood. Experientia 30: 924–926
Clarke L (1974) Dialysis of drugs in vitro. Br J Clin Pharmacol 1: 442–445
Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ, (1998) Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology 88:1071–1075
Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB, (2006) Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 105: 217–218
Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB, Weinberg GL, Henretig FM, (2008) Use of Lipid Emulsion in the Resuscitation of a Patient With Prolonged Cardiovascular Collapse After Overdose of Bupropion and Lamotrigine. Ann Emerg Med 51: 412–415.e1
Cave G, Harvey MG, (2014) Should we consider the infusion of lipid emulsion in the resuscitation of poisoned patients? Crit Care 18: 457
Ozcan MS, Weinberg G, (2014) Intravenous lipid emulsion for the treatment of drug toxicity. J Intensive Care Med 29: 59–70
Harvey M, Cave G, (2014) Lipid rescue: does the sink hold water? And other controversies. Br J Anaesth 112: 622–625
Weinberg GL, (2012) Lipid Emulsion Infusion. Anesthesiology 117: 180–187
Leroux JC, (2007) Injectable nanocarriers for biodetoxification. Nat Nanotechnol 2: 679–684
Mazoit JX, Le Guen R, Beloeil H, Benhamou D, (2009) Binding of long-lasting local anesthetics to lipid emulsions. Anesthesiology 110: 380–386
Laine J, Lokajová J, Parshintsev J, Holopainen JM, Wiedmer SK, (2010) Interaction of a commercial lipid dispersion and local anesthetics in human plasma: implications for drug trap** by “lipid-sinks”. Anal Bioanal Chem 396: 2599–2607
Weinberg G, Lin B, Zheng S, Di Gregorio G, Hiller D, Ripper R, Edelman L, Kelly K, Feinstein D, (2010) Partitioning effect in lipid resuscitation: further evidence for the lipid sink. Crit Care Med 38: 2268–2269
Weinberg GL, Ripper R, Murphy P, Edelman LB, Hoffman W, Strichartz G, Feinstein DL, (2006) Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med 31: 296–303
Niiya T, Litonius E, Petäjä L, Neuvonen PJ, Rosenberg PH, (2010) Intravenous lipid emulsion sequesters amiodarone in plasma and eliminates its hypotensive action in pigs. Ann Emerg Med 56: 402–408.e2
Heinonen JA, Litonius E, Backman JT, Neuvonen PJ, Rosenberg PH, (2013) Intravenous Lipid Emulsion Entraps Amitriptyline into Plasma and Can Lower its Brain Concentration-An Experimental Intoxication Study in Pigs. Basic Clin Pharmacol Toxicol 113: 193–200
French D, Smollin C, Ruan W, Wong A, Drasner K, Wu AH, (2011) Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies. Clin Toxicol 49: 801–809
Kuo I, Akpa BS, (2013) Validity of the Lipid Sink as a Mechanism for the Reversal of Local Anesthetic Systemic Toxicity. Anesthesiology 118: 1350–1361
Fettiplace MR, Lis K, Ripper R, Kowal K, Pichurko A, Vitello D, Rubinstein I, Schwartz D, Akpa BS, Weinberg G, (2015) Multimodal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion. J Control Release 198: 62–70
Heinonen JA, Litonius E, Backman JT, Neuvonen PJ, Rosenberg PH, (2013) Intravenous lipid emulsion entraps amitriptyline into plasma and can lower its brain concentration—an experimental intoxication study in pigs. Basic Clin Pharmacol Toxicol 113: 193–200
French D, Armenian P, Ruan W, Wong A, Drasner K, Olson KR, Wu AH, (2011) Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose. Clin Toxicol 49: 340–344
Harvey M, Cave G, (2012) Case report: successful lipid resuscitation in multi-drug overdose with predominant tricyclic antidepressant toxidrome. Int J Emerg Med 5: 8
Shi K, **a Y, Wang Q, Wu Y, Dong X, Chen C, Tang W, Zhang Y, Luo M, Wang X, Papadimos TJ, Xu X, (2013) The effect of lipid emulsion on pharmacokinetics and tissue distribution of bupivacaine in rats. Anesth Analg 116: 804–809
Perichon D, Turfus S, Gerostamoulos D, Graudins A, (2013) An assessment of the in vivo effects of intravenous lipid emulsion on blood drug concentration and haemodynamics following orogastric amitriptyline overdose. Clin Toxicol 51: 208–215
Harvey M, Cave G, Shaw T, (2013) Effect of intravenous lipid emulsion and octreotide on enteric thiopentone absorption; a pilot study. Clin Toxicol 51: 117–118
Marwick PC, Levin AI, Coetzee AR, (2009) Recurrence of cardiotoxicity after lipid rescue from bupivacaine-induced cardiac arrest. Anesth Analg 108: 1344–1346
Stehr SN, Ziegeler JC, Pexa A, Oertel R, Deussen A, Koch T, Hübler M, (2007) The effects of lipid infusion on myocardial function and bioenergetics in l-bupivacaine toxicity in the isolated rat heart. Anesth Analg 104: 186–192
Li J, Fettiplace M, Chen SJ, Steinhorn B, Shao Z, Zhu X, Li C, Harty S,Weinberg G, Van den Hoek TL, (2014) Lipid emulsion rapidly restores contractility in stunned mouse cardiomyocytes: a comparison with therapeutic hypothermia. Crit Care Med 42: e734–40
Lou PH, Lucchinetti E, Zhang L, Affolter A, Schaub MC, Gandhi M, Hersberger M, Warren BE, Lemieux H, Sobhi HF, Clanachan AS, Zaugg M, (2014) The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases. PLoS One 9: e87205
Fettiplace MR, Akpa BS, Ripper R, Zider B, Lang J, Rubinstein I, Weinberg G, (2014) Resuscitation with lipid emulsion: dosedependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect. Anesthesiology 120: 915–925
Fettiplace MR, Ripper R, Lis K, Lin B, Lang J, Zider B, Wang J, Rubinstein I, Weinberg G, (2013) Rapid cardiotonic effects of lipid emulsion infusion. Crit Care Med 41: e156–62
Wagner M, Zausig YA, Ruf S, Rudakova E, Gruber M, Graf BM, Volk T, (2014) Lipid rescue reverses the bupivacaine-induced block of the fast Na+ current (INa) in cardiomyocytes of the rat left ventricle. Anesthesiology 120: 724–736
Gueret G, Pennec JP, Arvieux CC, (2007) Hemodynamic effects of intralipid after verapamil intoxication may be due to a direct effect of fatty acids on myocardial calcium channels. Acad Emerg Med 14: 761
Ok SH, Park CS, Kim HJ, Lee SH, Choi BH, Eun SY, Kim KN, Yang SM, Shin IW, Choi MJ, Sohn JT, (2013) Effect of two lipid emulsions on reversing high-dose levobupivacaine-induced reduced vasoconstriction in the rat aortas. Cardiovasc Toxicol 13: 370–380
Hoegberg LC, Bania TC, Lavergne V, Bailey B, Turgeon AF, Thomas SH, Morris M, Miller-Nesbitt A, Mégarbane B, Magder S, Gosselin S; Lipid Emulsion Workgroup, (2016) Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity. Clin Toxicol 54: 167–193
Levine M, Hoffman RS, Lavergne V, Stork CM, Graudins A, Chuang R, Stellpflug SJ, Morris M, Miller-Nesbitt A, Gosselin S; Lipid Emulsion Workgroup, (2016) Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol 54: 194–221
Gosselin S, Morris M, Miller-Nesbitt A, Hoffman RS, Hayes BD, Turgeon AF, Gilfix BM, Grunbaum AM, Bania TC, Thomas SH, Morais JA, Graudins A, Bailey B, Mégarbane B, Calello DP, Levine M, Stellpflug SJ, Hoegberg LC, Chuang R, Stork C, Bhalla A, Rollins CJ, Lavergne V; AACT Lipid Emulsion Therapy workgroup, (2015) Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol 53: 557–564
Taftachi F, Sanaei-Zadeh H, Sepehrian B, Zamani N, (2012) Lipid emulsion improves Glasgow coma scale and decreases blood glucose level in the setting of acute non-local anesthetic drug poisoning—a randomized controlled trial. Eur Rev Med Pharmacol Sci 16 Suppl 1: 38–42
Gil HW, Park JS, Park SH, Hong SY, (2013) Effect of intravenous lipid emulsion in patients with acute glyphosate intoxication. Clin Toxicol 51: 767–771
Ludot H, Tharin JY, Belouadah M, Mazoit JX, Malinovsky JM, (2008) Successful Resuscitation After Ropivacaine and Lidocaine-Induced Ventricular Arrhythmia Following Posterior Lumbar Plexus Block in a Child. Anesth Analg 106: 1572–1574
Mazoit JX, Le Guen R, Beloeil H, Benhamou D, (2009) Binding of Long-lasting Local Anesthetics to Lipid Emulsions. Anesthesiology 110: 380–386
Fettiplace MR, Akpa BS, Rubinstein I, Weinberg G, (2015) Confusion About Infusion: Rational Volume Limits for Intravenous Lipid Emulsion During Treatment of Oral Overdoses. Ann Emerg Med 66: 185–188
Perez E, Bania TC, Medlej K, Chu J, (2008) Determining the optimal dose of intravenous fat emulsion for the treatment of severe verapamil toxicity in a rodent model. Acad Emerg Med 15: 1284–1289
Gosselin S, Hoegberg LC, Hoffman RS, Graudins A, Stork CM, Thomas SH, Stellpflug SJ, Hayes BD, Levine M, Morris M, Nesbitt-Miller A, Turgeon AF, Bailey B, Calello DP, Chuang R, Bania TC, Mégarbane B, Bhalla A, Lavergne V, (2016) Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol 54: 899–923
American College of Medical Toxicology, (2017) ACMT Position Statement: Guidance for the Use of Intravenous Lipid Emulsion. J Med Toxico l13: 124–125
Salmela L, Washington C, (2014) A continuous flow method for estimation of drug release rates from emulsion formulations. Int J Pharm 472: 276–281
Hiller DB, Gregorio GD, Ripper R, Kelly K, Massad M, Edelman L, Edelman G, Feinstein DL, Weinberg GL, (2009) Epinephrine impairs lipid resuscitation from bupivacaine overdose: a threshold effect. Anesthesiology 111: 498–505
Benhamou D, Mazoit JX, Zetlaoui P, (2010) [Early administration of lipid rescue after initial signs of local anesthetic-induced systemic toxicity]. Ann Fr Anesth Reanim 29: 826
Hayes BD, Gosselin S, Calello DP, Nacca N, Rollins CJ, Abourbih D, Morris M, Nesbitt-Miller A, Morais JA, Lavergne V; Lipid Emulsion Workgroup, (2016) Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol 54: 365–404
Grunbaum AM, Gilfix BM, Hoffman RS, Lavergne V, Morris M, Miller-Nesbitt A, Gosselin S, (2016) Review of the effect of intravenous lipid emulsion on laboratory analyses. Clin Toxicol 54: 92–102
Forster V, Leroux JC, (2015) Nano-antidotes for drug overdose and poisoning. Sci Transl Med 7: 290ps14
Muhammad F, Nguyen TD, Raza A, Akhtar B, Aryal S, (2017) A review on nanoparticle-based technologies for biodetoxification. Drug Chem Toxicol 40: 489–497
Rahman YE, Rosenthal MW, Cerny EA, (1973) Intracellular plutonium: removal by liposome-encapsulated chelating agent. Science 180: 300–302
Allen TM, Cullis PR, (2013) Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65: 36–48
Forster V, Luciani P, Leroux JC, (2012) Treatment of calcium channel blocker-induced cardiovascular toxicity with drug scavenging liposomes. Biomaterials 33: 3578–3585
Forster V, Signorell RD, Roveri M, Leroux JC, (2014) Liposomesupported peritoneal dialysis for detoxification of drugs and endogenous metabolites. Sci Transl Med 6: 258ra141
Szilasi M, Budai M, Budai L, Petrikovics I, (2012) Nanoencapsulated and microencapsulated enzymes in drug antidotal therapy. Toxicol Ind Health 28: 522–531
Buys M, Scheepers PA, Levin AI, (2015) Lipid emulsion therapy: non-nutritive uses of lipid emulsions in anaesthesia and intensive care. South Afr J Anaesth Analg 21: 124–130
Corriol O, (2007) Nutrition parentérale: produits. In: Traité de nutrition artificielle de l’adulte. Springer, Paris, p. 625–634
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jaffal, K., Chevillard, L. & Megarbane, B. Place des émulsions lipidiques intraveineuses en toxicologie. Méd. Intensive Réa 26, 373–382 (2017). https://doi.org/10.1007/s13546-017-1299-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13546-017-1299-3
Mots clés
- Émulsion lipidique
- Intralipide®
- Intoxication
- Cardiotrope
- Choc toxique
- Insuffisance circulatoire
- Arrêt cardiaque